Poor Response to Albendazole in Hookworm‐Infected Abnormal Haemoglobin Carriers
Tropical Medicine & International Health · 2026
DOI: 10.1111/tmi.70093 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Tropical Medicine & International Health, 2026. Verfasst von Attarat Pattanawongsa und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand. Hauptthemen laut MEDLINE: Albendazole, Hookworm Infections, Hemoglobins, Anthelmintics. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
In southern Thailand, the low efficacy of albendazole contributes to the unsuccessful elimination of hookworms. Individuals infected with hookworms exhibiting low albendazole efficacy show decreased mean corpuscular volume and mean corpuscular haemoglobin and are suspected carriers of abnormal haemoglobin. This observational study aimed to compare the treatment outcomes of albendazole for hookworm infection in individuals with normal versus abnormal haemoglobin types.
Methods
227 stool samples were examined using the Kato‐Katz and agar plate culture methods. Blood samples were collected from participants with hookworm‐positive stool after oral administration of 400 mg albendazole to perform complete blood counts and haemoglobin typing. Treatment outcomes were evaluated 3 weeks after albendazole administration. Participants with persistent hookworm infection received a second 400 mg dose of albendazole, and outcomes were reassessed 3 weeks later.
Results
Among 54 hookworm‐positive participants, 38 were cured after the first round of treatment, and 5 were cured after the second round, all of whom had normal haemoglobin. However, 11 participants remained uncured after two treatment rounds, all with abnormal haemoglobin types: 7 with heterozygous haemoglobin E, 3 with heterozygous haemoglobin constant spring (CS) and 1 with compound heterozygous haemoglobin E/CS.
Conclusion
These findings suggest that abnormal haemoglobin may be a host factor contributing to low albendazole efficacy in treating hookworm infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand.
- Drug and Cosmetics Excellence Center, Walailak University, Nakhon Si Thammarat, Thailand.
- School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
- Hematology and Transfusion Science Research Center, Walailak University, Nakhon Si Thammarat, Thailand.
- Department of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
- Research Center in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat, Thailand.
ORCID-Profile: Patthanasak Khammaneechan, Witthaya Anamnart
Zitieren
APA
Pattanawongsa, A., Nuinoon, M., Na-Ek, P., Khammaneechan, P., Sedionoto, B., & Anamnart, W. (2026). Poor Response to Albendazole in Hookworm‐Infected Abnormal Haemoglobin Carriers. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70093
Vancouver
Pattanawongsa A, Nuinoon M, Na-Ek P, Khammaneechan P, Sedionoto B, Anamnart W. Poor Response to Albendazole in Hookworm‐Infected Abnormal Haemoglobin Carriers. Tropical Medicine & International Health. 2026. doi:10.1111/tmi.70093
BibTeX
@article{Pattanawongsa2026,
author = {Pattanawongsa, Attarat and Nuinoon, Manit and Na-Ek, Prasit and Khammaneechan, Patthanasak and Sedionoto, Blego and Anamnart, Witthaya},
title = {Poor Response to Albendazole in Hookworm‐Infected Abnormal Haemoglobin Carriers},
journal = {Tropical Medicine & International Health},
year = {2026},
doi = {10.1111/tmi.70093}
}
EUVIMED